Efficacy of sibutramine in different types of eating behavior in obese patients ; Эффективность применения сибутрамина при различных типах нарушений пищевого поведения у пациентов с ожирением
Introduction. One of the key factors contributing to the development and progression of obesity is impairment eating behavior (EB). Therefore, drug therapy for obesity should not only reduce hunger, contributing to weight loss, but also reducing the severity of EB disorders.Aim. Assess the representation of different types of EB in obese patients, the effect of sibutramine therapy on dynamics EB by The Dutch Eating Behavior Questionnaire (DEBQ) and for hunger/satiety on a visual analog scale (VAS). Quality life of patients, adherence to treatment of obese patients and their weight dynamics in... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2022 |
Verlag/Hrsg.: |
REMEDIUM GROUP Ltd.
|
Schlagwörter: | ВАШ (визуально-аналоговая шкала чувства голода/сытости) / sibutramine / eating behavior / The Dutch Eating Behavior Questionnaire (DEBQ) / HADS (Hospital Anxiety and Depression Scale) / VAS (visual analogue scale of hunger/fullness) / сибутрамин / пищевое поведение / голландский опросник пищевого поведения |
Sprache: | Russian |
Permalink: | https://search.fid-benelux.de/Record/base-27413908 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://www.med-sovet.pro/jour/article/view/6941 |